New Clinical Trial to Study IBD and Graft-Versus-Host Disease in Children

New Clinical Trial to Study IBD and Graft-Versus-Host Disease in Children
A new clinical trial at Seattle Children’s Hospital aims to provide doctors with information about how inflammatory bowel disease (IBD) develops in children. The goal is to find strategies for clinicians to personalize treatments. The PREDICT (Precision Diagnostics in Inflammatory Bowel Disease, Cellular Therapy and Transplantation) study will employ next-generation sequencing and gene expression analyses to

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *